AAAAAA
Results:
1-9
|
Results: 9
Authors:
Maurer, I
Zierz, S
Moller, HJ
Citation: I. Maurer et al., Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia, SCHIZOPHR R, 48(1), 2001, pp. 125-136
Authors:
Maurer, I
Volz, HP
Citation: I. Maurer et Hp. Volz, Cell-mediated side effects of psychopharmacological treatment, ARZNEI-FOR, 51(10), 2001, pp. 785-792
Authors:
Maurer, I
Zierz, S
Moller, HJ
Citation: I. Maurer et al., A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients, NEUROBIOL A, 21(3), 2000, pp. 455-462
Authors:
Volz, HP
Riehemann, S
Maurer, I
Smesny, S
Sommer, M
Rzanny, R
Holstein, W
Czekalla, J
Sauer, H
Citation: Hp. Volz et al., Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: A P-31 chemical shift spectroscopic-imaging study, BIOL PSYCHI, 47(11), 2000, pp. 954-961
Authors:
Maurer, I
Volz, HP
Sauer, H
Citation: I. Maurer et al., Gabapentin leads to remission of somatoform pain disorder with major depression, PHARMACOPS, 32(6), 1999, pp. 255-257
Authors:
Maurer, I
Volz, HP
Citation: I. Maurer et Hp. Volz, Lipid supplementation in schizophrenia, BR J PSYCHI, 175, 1999, pp. 287-288
Authors:
Volz, HP
Rossger, G
Riehemann, S
Hubner, G
Maurer, I
Wenda, B
Rzanny, R
Kaiser, WA
Sauer, H
Citation: Hp. Volz et al., Increase of phosphodiesters during neuroleptic treatment of schizophrenics: A longitudinal P-31-magnetic resonance spectroscopic study, BIOL PSYCHI, 45(9), 1999, pp. 1221-1225
Authors:
Maurer, I
Zierz, S
Citation: I. Maurer et S. Zierz, Recurrent orbital myositis - Report of a familial incidence, ARCH NEUROL, 56(11), 1999, pp. 1407-1409
Authors:
Maurer, I
Zierz, S
Moller, HJ
Citation: I. Maurer et al., Carnitine acyltransferases are not changed in Alzheimer disease, ALZ DIS A D, 12(2), 1998, pp. 71-76
Risultati:
1-9
|